Nom du produit:1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-amine
IUPAC Name:1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-amine
- CAS：787585-36-8
- Formule moléculaire：C10H13ClFN
- Pureté：95%+
- Numéro de catalogue：CM674541
- Poids moléculaire：201.67
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:787585-36-8
- Formule moléculaire:C10H13ClFN
- Point de fusion:-
- Code SMILES:CC(C)(N)CC1=CC(F)=C(Cl)C=C1
- Densité:
- Numéro de catalogue:CM674541
- Poids moléculaire:201.67
- Point d'ébullition:
- N° Mdl:MFCD24624311
- Stockage:
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Encaleret
- New England Journal of Medicine(NEJM) publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (ADH1).
Encaleret is an investigational, orally administered small molecule that selectively antagonizes the calcium sensing receptor (CaSR), targeting ADH1 at its source. If approved, encaleret could be the first therapy specifically indicated for the treatment of ADH1.
Encaleret has received fast track designation by the U.S. FDA and orphan drug designation in the United States and the European Union.
Recherche 
+86 21 5895 0110 
